HomeCompareEKTAF vs QYLD

EKTAF vs QYLD: Dividend Comparison 2026

EKTAF yields 4.14% · QYLD yields 11.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EKTAF wins by $63.6K in total portfolio value
10 years
EKTAF
EKTAF
● Live price
4.14%
Share price
$6.20
Annual div
$0.26
5Y div CAGR
33.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$89.0K
Annual income
$24,064.33
Full EKTAF calculator →
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
11.92%
Share price
$17.15
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.4K
Annual income
$5,659.31
Full QYLD calculator →

Portfolio growth — EKTAF vs QYLD

📍 EKTAF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEKTAFQYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EKTAF + QYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EKTAF pays
QYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EKTAF
Annual income on $10K today (after 15% tax)
$352.23/yr
After 10yr DRIP, annual income (after tax)
$20,454.68/yr
QYLD
Annual income on $10K today (after 15% tax)
$1,013.51/yr
After 10yr DRIP, annual income (after tax)
$4,810.41/yr
At 15% tax rate, EKTAF beats the other by $15,644.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EKTAF + QYLD for your $10,000?

EKTAF: 50%QYLD: 50%
100% QYLD50/50100% EKTAF
Portfolio after 10yr
$57.2K
Annual income
$14,861.82/yr
Blended yield
25.97%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EKTAF buys
0
QYLD buys
0
No recent congressional trades found for EKTAF or QYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEKTAFQYLD
Forward yield4.14%11.92%
Annual dividend / share$0.26$2.04
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR33.2%0%
Portfolio after 10y$89.0K$25.4K
Annual income after 10y$24,064.33$5,659.31
Total dividends collected$61.5K$27.1K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: EKTAF vs QYLD ($10,000, DRIP)

YearEKTAF PortfolioEKTAF Income/yrQYLD PortfolioQYLD Income/yrGap
1← crossover$11,252$551.96$10,352$1,192.36+$900.00EKTAF
2$12,813$773.14$10,830$1,347.57+$2.0KEKTAF
3$14,806$1,095.96$11,460$1,539.07+$3.3KEKTAF
4$17,418$1,576.51$12,275$1,777.84+$5.1KEKTAF
5$20,947$2,308.89$13,323$2,078.95+$7.6KEKTAF
6$25,869$3,456.43$14,667$2,463.34+$11.2KEKTAF
7$32,994$5,313.97$16,396$2,960.57+$16.6KEKTAF
8$43,741$8,437.06$18,631$3,612.97+$25.1KEKTAF
9$60,727$13,923.91$21,548$4,482.15+$39.2KEKTAF
10$89,042$24,064.33$25,398$5,659.31+$63.6KEKTAF

EKTAF vs QYLD: Complete Analysis 2026

EKTAFStock

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Full EKTAF Calculator →

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →
📬

Get this EKTAF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EKTAF vs SCHDEKTAF vs JEPIEKTAF vs OEKTAF vs KOEKTAF vs MAINEKTAF vs XYLDEKTAF vs JEPQEKTAF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.